Australia | Sanofi v Amgen dispute update
Federal Court dismisses Sanofi’s appeal and orders that Amgen’s Repatha patent applications proceed to grant, offering key lessons for other antibody patents approaching the end of their term. The global...
Federal Court dismisses Sanofi’s appeal and orders that Amgen’s Repatha patent applications proceed to grant, offering key lessons for...
Read More
Sanofi v Amgen dispute: Australian update
It’s one of the most consequential pharmaceutical patent disputes in years, one that is being closely watched by practitioners around the world. The patent litigation concerning Amgen’s PCSK9 antibody...
It’s one of the most consequential pharmaceutical patent disputes in years, one that is being closely watched by practitioners...
Read More
ToolGen unsuccessful in landmark CRISPR patent appeal
The Federal Court of Australia has delivered judgement in Australia’s landmark CRISPR patent dispute, finding that none of the claims in ToolGen Inc.’s patent application for platform CRISPR technologies...
The Federal Court of Australia has delivered judgement in Australia’s landmark CRISPR patent dispute, finding that none of the...
Read More
Understanding Australia’s Experimental Use Exemption to Patent Infringement
Background to Patent Infringement An Australian patent provides to its owner the exclusive rights to exploit a patented invention during the patent term within Australia. The owner has a legal...
Background to Patent Infringement An Australian patent provides to its owner the exclusive rights to exploit a patented invention during...
Read More
Australian patent office refuses to extend the time for making biological deposits
The Budapest Treaty provides a mechanism whereby patent applicants can sufficiently “describe” a biological invention by making a deposit of biological material with a recognised international depositary authority. To...
The Budapest Treaty provides a mechanism whereby patent applicants can sufficiently “describe” a biological invention by making a deposit...
Read More
Keywords go viral: Covid-19 sweeps around the patent world
Covid-19 is not just a once-in-a-lifetime pandemic sweeping across the globe causing hardships and sorrows; it’s also a new word, and the opportunity to look at it through a...
Covid-19 is not just a once-in-a-lifetime pandemic sweeping across the globe causing hardships and sorrows; it’s also a new...
Read More
Validity and infringement of diagnostic method claims
Ariosa Diagnostics, Inc v Sequenom, Inc FCAFC 101 The Full Court of the Federal Court of Australia has confirmed that Sequenom’s diagnostic method of detecting fetal DNA in maternal...
Ariosa Diagnostics, Inc v Sequenom, Inc FCAFC 101 The Full Court of the Federal Court of Australia has confirmed...
Read More
Australian Patent Office considers the plausibility of Swiss-style claims
Gliknik, Inc. v CSL Behring Lengnau AG  APO 46 (“Gliknik”) concerned a patent application for engineered proteins intended for use as replacements for intravenous immunoglobulin.  The application included claims...
Gliknik, Inc. v CSL Behring Lengnau AG  APO 46 (“Gliknik”) concerned a patent application for engineered proteins intended for...
Read More

Contact our Expert Team

Contact Us
Contact Us